AI-Driven Insights into the complexities of Chinese hamster ovary cells death in order to optimize production processes

Author:

Moshfeghnia MohammadORCID

Abstract

AbstractChinese hamster ovary (CHO) cells are a multipurpose and high-performance cell line for recombinant protein production in biopharmaceutical industry. They have proven their ability to produce a wide range of therapeutic proteins with high efficiency and quality. Designing novel and high-performance CHO cell lines has an incredible impact in biopharmaceutical industry that can reduce prices and increase product efficiency. One of the best ways is to prevent CHO cells death during Bioprocessing. Apoptosis is the most common form of CHO cells death during Bioprocessing. Analyzing Apoptosis and cell-cycle complex signaling pathways are necessary for the control of cell growth, efficiency, and the death of CHO cells. Therefore, analyzing and understanding interactions of these pathways and their interactions with other cellular processes can help optimize the performance and quality of CHO cell lines. AI-driven insight solutions and Advanced machine learning algorithms like GAT (Graph Attention Network) used in this project indicate most important Targets in complex signaling pathways. Pathways such as the TNF signaling pathway, and also viruses like: Hepatitis C, HIV1 and Bacteria like: Salmonella have High intersection size and Low P-value with complex signaling pathways. These microorganisms should be used to design high-performance CHO cell lines because they are master in these pathways. This method can be used to find novel and high efficiency targets for curing cancer in humans.

Publisher

Cold Spring Harbor Laboratory

Reference127 articles.

1. Recombinant protein therapeutics from CHO cells : 20 years and counting;Chemical Engineering Progress,2007

2. M. Pereira , “CHO in biomanufacturing: Past, present and future,” European Pharmaceutical Manufacturer, 01-Jun-2021. [Online]. Available: https://pharmaceuticalmanufacturer.media/pharmaceutical-industry-insights/biopharma-news/cho-in-biomanufacturing-past-present-and-future. [Accessed: 02-Dec-2023].

3. “HEK cells vs. CHO cells in recombinant antibody production: What’s the better choice,” Pharmiweb.com, 03-Mar-2022. [Online]. Available: https://www.pharmiweb.com/article/hek-cells-vs-cho-cells-in-recombinant-antibody-production-whats-the-better-choice. [Accessed: 02-Dec-2023].

4. Exploring the molecular content of CHO exosomes during bioprocessing

5. The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3